Phase shifts to light are altered by antagonists to neuropeptide receptors

Simple item page
dc.contributor.authorChan, Ryan K
dc.contributor.authorSterniczuk, Roxanne
dc.contributor.authorEnkhbold, Yaruuna
dc.contributor.authorJeffers, Ryan T
dc.contributor.authorBasu, Priyoneel
dc.contributor.authorDuong, Bryan
dc.contributor.authorChow, Sue-Len
dc.contributor.authorSmith, Victoria M
dc.contributor.authorAntle, Michael C
dc.date.accessioned2016-05-18T21:27:57Z
dc.date.available2016-05-18T21:27:57Z
dc.date.issued2016-07-07
dc.description.abstractThe mammalian circadian clock in the suprachiasmatic nucleus (SCN) is a heterogeneous structure. Two key populations of cells that receive retinal input and are believed to participate in circadian responses to light are cells that contain vasoactive intestinal polypeptide (VIP) and gastrin-releasing peptide (GRP). VIP acts primarily through the VPAC2 receptor while GRP works primarily through the BB2 receptor. Both VIP and GRP phase shift the circadian clock in a manner similar to light when applied to the SCN, both in vivo and in vitro, indicating that they are sufficient to elicit photic-like phase shifts. However, it is not known if they are necessary signals for light to elicit phase shifts. Here we test the hypothesis that GRP and VIP are necessary signaling components for photic phase shifting the hamster circadian clock by testing two antagonists for each of these neuropeptides. The BB2 antagonist PD176252 had no effect on light-induced delays on its own, while the BB2 antagonist RC-3095 had the unexpected effect of significantly potentiating both phase delays and advances. Neither of the VIP antagonists ([D-p-Cl-Phe6, Leu17]-VIP, or PG99-465) altered phase shifting responses to light on its own. When the BB2 antagonist PD176252 and the VPAC2 antagonist PG99-465 were delivered together to the SCN, phase delays were significantly attenuated. These results indicate that photic phase shifting requires participation of either VIP or GRP, and only when signaling in both pathways is inhibited are phase shifts to light impaired. Additionally, the unexpected potentiation of light induced phase shifts by RC-3095 should be investigated further for potential chronobiotic applications.en_US
dc.description.grantingagencyNSERCen_US
dc.description.refereedYesen_US
dc.identifier.doi10.1016/j.neuroscience.2016.04.010
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/33344
dc.identifier.grantnumberRGPIN-2016-04059en_US
dc.identifier.urihttp://hdl.handle.net/1880/51233
dc.publisherElsevieren_US
dc.publisher.departmentPsychologyen_US
dc.publisher.facultyArtsen_US
dc.publisher.institutionUniversity of Calgaryen_US
dc.titlePhase shifts to light are altered by antagonists to neuropeptide receptorsen_US
dc.typejournal article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
60-Chan et al 2016 - Accepted manuscript.pdf
Size:
737.76 KB
Format:
Adobe Portable Document Format
Description:
Post-print/accepted manuscript
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.84 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Arts Research & Publications